Clinical Trials List
Protocol NumberGR42691
Completed
2021-05-01 - 2024-12-31
Phase III
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 劉珍吟 Division of Ophthalmology
- Yih-Shiou Hwang Division of Ophthalmology
- 周宏達 Division of Ophthalmology
- 沈惠真 Division of Ophthalmology
- 陳冠任 Division of Ophthalmology
- 陳彥伯 Division of Ophthalmology
- Wei-Chi WU Division of Ophthalmology
- 簡如伶 Division of Ophthalmology
- 陳墩祿 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林伯剛 無
- 周昱百 無
- 林泰祺 無
- 黃怡銘 無
- De-Kuang Hwang 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
19 participants
-
Global
1280 participants